We report the case of a 4-year-old female with a primary extradural intramedullary atypical teratoid/rhabdoid tumor (AT/RT) leading to a middle cerebral artery (MCA) infarct and Froin's syndrome. She presented with a 6-pound weight loss over the previous week, as well as a decreased urinary output and an altered mental status. She underwent a brain MRI that revealed a left MCA infarct, mild ventriculomegaly, and bilateral internal carotid artery, M1, and A1 stenosis. An external ventricular drain (EVD) was placed due to increased intracranial pressure. Cerebrospinal fluid (CSF) was analyzed via lumbar puncture that revealed extremely elevated protein. However, CSF sampled from the EVD was completely normal, a phenomenon called Froin's syndrome. The following day, she developed a right MCA infarct. Her grim prognosis was discussed with her family and care was eventually withdrawn. The patient underwent an autopsy which confirmed a spinal AT/RT. To our knowledge, this is the first reported case of stroke and Froin's syndrome as the initial manifestations of a primary spinal AT/RT with a late onset of spinal cord compression due to tumor obstruction.

1.
Rorke LB, Packer RJ, Biegel JA: Central nervous system atypical teratoid/rhabdoid tumors of infancy and childhood: definition of an entity. J Neurosurg 1996;85:56-65.
2.
Hilden JM, Meerbaum S, Burger P, Finlay J, Janss A, Scheithauer BW, Walter AW, Rorke LB, Biegel JA: Central nervous system atypical teratoid/rhabdoid tumor: results of therapy in children enrolled in a registry. J Clin Oncol 2004;22:2877-2884.
3.
Kodama H, Maeda M, Imai H, Matsubara T, Taki W, Takeda K: MRI of primary spinal atypical teratoid/rhabdoid tumor: a case report and literature review. J Neurooncol 2007;84:213-216.
4.
Bannykh S, Duncan C, Ogle E, Baehring JM: Atypical teratoid/rhabdoid tumor of the spinal canal. J Neurooncol 2006;76:129-130.
5.
Yang CS, Jan YJ, Wang J, Shen CC, Chen CC, Chen M: Spinal atypical teratoid/rhabdoid tumor in a 7-year-old boy. Neuropathology 2007;27:139-144.
6.
Behdad A, Perry A: Central nervous system primitive neuroectodermal tumors: a clinicopathologic and genetic study of 33 cases. Brain Pathol 2010;20:441-450.
7.
Biegel JA: Molecular genetics of atypical teratoid/rhabdoid tumor. Neurosurg Focus 2006;20:E11.
8.
Raisanen J, Biegel JA, Hatanpaa KJ, Judkins A, White CL, Perry A: Chromosome 22q deletions in atypical teratoid/rhabdoid tumors in adults. Brain Pathol 2005;15:23-28.
9.
Seno T, Kawaguchi T, Yamahara T, Sakurai Y, Oishi T, Inagaki T, Yamanouchi Y, Asai A, Kawamoto K: An immunohistochemical and electron microscopic study of atypical teratoid/rhabdoid tumor. Brain Tumor Pathol 2008;25:79-83.
10.
Tinsa F, Jallouli M, Douira W, Boubaker A, Kchir N, Hassine DB, Boussetta K, Bousnina S: Atypical teratoid/rhabdoid tumor of the spine in a 4-year-old girl. J Child Neurol 2008;23:1439-1442.
11.
Dancel R, Shaban M: Images in clinical medicine: Froin's syndrome. N Engl J Med 2016;374:1076.
12.
Hammes EM: A tumor of the cauda equina with the Froin syndrome. Arch Neurol Psychiatry 1924;11:82-84.
13.
Ljevak J, Poljakovic Z, Adamec I, Habek M: Glioblastoma multiforme presenting as Froin's syndrome: a new face of an old foe. Acta Neurol Belg 2014;114:319-320.
14.
Fridley JS, Chamoun RB, Whitehead WE, Curry DJ, Luerssen TG, Adesina A, Jea A: Malignant rhabdoid tumor of the spine in an infant: case report and review of the literature. Pediatr Neurosurg 2009;45:237-243.
15.
Biegel JA, Tan L, Zhang F, Wainwright L, Russo P, Rorke LB: Alterations of the hSNF5/INI1 gene in central nervous system atypical teratoid/rhabdoid tumors and renal and extrarenal rhabdoid tumors. Clin Cancer Res 2002;8:3461-3467.
16.
Tamiya T, Nakashima H, Ono Y, Kawada S, Hamazaki S, Furuta T, Matsumoto K, Ohmoto T: Spinal atypical teratoid/rhabdoid tumor in an infant. Pediatr Neurosurg 2000;32:145-149.
17.
Moeller KK, Coventry S, Jernigan S, Moriarty TM: Atypical teratoid/rhabdoid tumor of the spine. AJNR Am J Neuroradiol 2007;28:593-595.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.